Perfusion-Dependent Focal Neurologic Deficits in a Critically Ill Heart Transplant Recipient: A Case of Tacrolimus-Associated Reversible Cerebral Vasospasm Syndrome?
orthotopic heart transplant
posterior reversible encephalopathy syndrome
reversible cerebral vasospasm syndrome
reversible posterior leukoencephalopathy syndrome
tacrolimus
Journal
Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
26
03
2023
accepted:
30
03
2023
medline:
28
6
2023
pubmed:
30
4
2023
entrez:
29
4
2023
Statut:
ppublish
Résumé
TACROLIMUS, a mainstay of immunosuppression after orthotopic heart transplantation (OHT), is associated with a broad range of side effects. Vasoconstriction caused by tacrolimus has been proposed as a mechanism underlying common side effects such as hypertension and renal injury. Neurologic side effects attributed to tacrolimus include headaches, posterior reversible encephalopathy syndrome (PRES), or reversible cerebral vasospasm syndrome (RCVS). Six case reports have been published describing RCVS in the setting of tacrolimus administration after OHT. The authors report a case of perfusion-dependent focal neurologic deficits attributed to tacrolimus-induced RCVS in an OHT recipient.
Identifiants
pubmed: 37120321
pii: S1053-0770(23)00235-5
doi: 10.1053/j.jvca.2023.03.044
pii:
doi:
Substances chimiques
Tacrolimus
WM0HAQ4WNM
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1487-1494Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest None.